10 killed in explosion at Chinese pharma plant

fire
A fire and explosion at a pharmaceutical plant in China was the second fatal blast in less than a month. (Pixabay)

Although China has made efforts to boost safety in its chemical manufacturing sector, deadly accidents are still considered common. An explosion and fire at a Chinese drug manufacturing plant proved deadly Monday when 10 workers were reportedly killed by smoke inhalation.

The explosion at the Qilu Tianhe Huishi Pharmaceutical Co. facility in eastern Shandong province was ignited by sparks from a pipe being welded at the plant, Rappler reported, citing state news agency Xinhua. A dozen rescue workers also were hurt but were not in life-threatening condition, the agency said.

RELATED: U.K. cites the GSK China plant that was damaged by explosions

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

An investigation has reportedly been launched. According to Rappler, Qilu Tianhe has invested about 1 billion yuan ($150 million) in the 280,000-square-meter facility in Jinan. 

The publication said this blast follows by a month an explosion at a chemical plant in eastern Jiangsu province that killed 78 and injured hundreds. In 2015, GlaxoSmithKline had to stop production at a plant in Tianjin after a series of explosions and a massive fire at a chemical storage warehouse in the industrial district killed 160 and caused widespread damage. No one at the GSK plant was injured by the nearby blast, but the facility was damaged. 

Suggested Articles

Alcon has many "mass and structural advantages" over "distant" follower Bausch, which spends a lot less on R&D, says one analyst.

The judge in a multistate case against opioid makers scoffed at their request for more time to review an estimate that they owe $480 billion in damages.

Indian drugmakers pick up U.S. generics scripts; Chi-Med files for Hong Kong listing; an explosion at a Qilu Pharma subsidiary kills 10.